DEMOPULOS, Gregory A.,FERGUSON, Kenneth M.,LAMBERT, William Joseph,WHITAKER, John Steven
申请号：
AU2018322032
公开号：
AU2018322032A1
申请日:
2018.08.21
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to therapeutic methods of using stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, and kits comprising the formulations for treating subjects suffering from atypical hemolytic uremic syndrome (aHUS).
